Evidence map›Paper›PMID 35992619›Full record

ArticleCanadian liver journal2018

Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Carla S Coffin, Scott K Fung, Fernando Alvarez, Curtis L Cooper, Karen E Doucette, Claire Fournier, Erin Kelly, Hin Hin Ko, Mang M Ma, Steven R Martin and 4 more

Open access · greenAbstract read
In one paragraph

Article in Canadian liver journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Barriers to Hepatitis B Treatment: A Multicentre Cross-Sectional Registry and Survey Study by the Canadian Hepatitis B Network.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Estimated prevalence of hepatitis B and C among immigrants in Canada.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

Carla S CoffinCumming School of Medicine, University of Calgary, Calgary, Alberta.
Scott K FungFaculty of Medicine, University of Toronto, Toronto, Ontario.
Fernando AlvarezCentre hospitalier de l'université de Montréal (CHUM)-CHU Sainte-Justine, Montreal, Québec.
Curtis L CooperDivision of Infectious Diseases, Department of Medicine, University of Ottawa, Ottawa, Ontario.
Karen E DoucetteDivision of Infectious Diseases, University of Alberta, Edmonton, Alberta.
Claire FournierDepartment of Medicine, Université de Montréal, Montreal, Québec.
Erin KellyDivision of Gastroenterology, Department of Medicine, University of Ottawa, Ottawa, Ontario.
Hin Hin KoFaculty of Medicine, University of British Columbia, Vancouver, British Columbia.
Mang M MaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta.
Steven R MartinPediatrics, Alberta Children's Hospital, Calgary, Alberta.
Carla OsiowyViral Hepatitis and Bloodborne Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba.
Alnoor RamjiSt. Paul's Hospital, Vancouver, British Columbia.
Edward TamLAIR Centre, Vancouver, British Columbia.
Jean Pierre VilleneuveDepartment of Medicine, Université de Montréal, Montreal, Québec.
Université de Montréal · CAUniversity of Alberta · CAUniversity of Ottawa · CAAlberta Children's Hospital · CACentre Hospitalier Universitaire Sainte-Justine · CAPublic Health Agency of Canada · CASt. Paul's Hospital · CAUniversity of British Columbia · CAUniversity of Calgary · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping with evolving evidence and understanding of HBV pathogenesis, the Canadian Association for the Study of Liver Disease periodically publishes HBV management guidelines. The goals of the 2018 guidelines are to (1) highlight the public health impact of HBV infection in Canada and the need to improve diagnosis and linkage to care, (2) recommend current best-practice guidelines for treatment of HBV, (3) summarize the key HBV laboratory diagnostic tests, and (4) review evidence on HBV management in special patient populations and include more detail on management of HBV in pediatric populations. An overview of novel HBV tests and therapies for HBV in development is provided to highlight the recent advances in HBV clinical research. The aim and scope of these guidelines are to serve as an up-to-date, comprehensive resource for Canadian health care providers in the management of HBV infection.

Indexed as

Association of Medical Microbiology and Infectious Disease (AMMI) CanadaCanadian Association for the Study of Liver Disease (CASL)guidelineshepatitis B

Identifiers

PMID35992619
PMCPMC9202759
OpenAlexW2904685328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.